Free Biopharma Stock Content

$XBI $131.83 -1.5% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

Summary: FGEN stock has been on a long-term downward cycle since peaking in 2018, mainly because of complications/miscommunications...

$XBI $133.8 +1.4% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

$XBI $131.91 +0.43% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

$XBI $131.35 -1.7% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

$XBI $133.6 -2.2% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

$XBI $136.56 -1.39% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

$XBI $138.5 +2.3% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

$XBI $135.40 -0.40% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

Summary: CVM reported its long-awaited Phase 3 results from its head & neck cancer trial for its immuno-therapy agent, Multikine, on June...

$XBI $135.7 -1.5% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

$XBI $137.85 -0.60 % Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

Summary 21 companies in our database with ovarian cancer drug candidates in clinical trials There are 5 assets that are currently in...

Free PDUFA Report: Listing current months PDUFA dates Use this info: To update your holdings before an approval To find bullish or...

Summary The first in vivo clinical trial results using in vivo CRISPR gene editing technology were reported yesterday (6/26/21) by...

$XBI $138.7 +1.0% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...

Summary Every month we identify biotech Big-Mover stocks with key upcoming clinical trial readouts. Starting in April 2023, we will be...

$XBI $137.3 +2.2% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days...

Summary Biotech companies continue to focus on Alzheimer’s disease with some promising early clinical data this year. There have been...

$XBI $134.31 +0.50% Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30...